ViewRay Inc (OTCPK:VRAYQ)
$ 0.00001 0 (0%) Market Cap: 2,000.00 Enterprise Value: 3.84 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

ViewRay Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 18, 2020 / 03:00PM GMT
Release Date Price: $3.18 (+2.91%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

Well, good morning, everyone. Welcome to Morgan Stanley Healthcare Conference 2020 here on day 5. My name is David Lewis, medical device analyst of Morgan Stanley, and thanks for being us here this morning.

As we've been doing the last kind of 1.5 days, we would transition from sort of large-cap medical devices to emerging growth medtech here on Thursday. And again, on Friday, it's my pleasure to have with this year kind of consistent with that theme, ViewRay and 2 members of management, Scott Drake, CEO; and Shar Matin, the COO. Just before I begin, remember, go to the Morgan Stanley website, /researchdisclosures to see fun facts about me and all of our research disclosures. And now we're going to jump into it.

Scott, do you want to give any kind of preamble comments? Or do you want to jump straight into Q&A?

Scott William Drake
ViewRay, Inc. - President, CEO & Director

Let's jump right in, David, but let me first thank you for the opportunity to be with you here. And I hope

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot